These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1413 related articles for article (PubMed ID: 21514247)

  • 21. Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.
    Huded CB; Bharath S; Chandra SR; Sivakumar PT; Varghese M; Subramanian S
    Asian J Psychiatr; 2015 Feb; 13():44-7. PubMed ID: 25468261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.
    Gauthier S; Patterson C; Gordon M; Soucy JP; Schubert F; Leuzy A
    Alzheimers Dement; 2011 May; 7(3):330-2. PubMed ID: 21575874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application guidelines and research progress of biomarkers for Alzheimer's disease].
    Wang XY; Li M; Lu ZM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Mar; 56(3):262-269. PubMed ID: 35381646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
    Beach TG; Monsell SE; Phillips LE; Kukull W
    J Neuropathol Exp Neurol; 2012 Apr; 71(4):266-73. PubMed ID: 22437338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Validity Comparison Between Criteria Based on CSF Alzheimer's Disease Biomarkers.
    Blanco-Cantó ME; Monge-Argilés JA; Pérez-Cejuela C; Badía C; Gabaldón L; Muñoz-Ruíz C; Sánchez-Payá J; Gasparini-Berenguer R; Leiva-Santana C
    Am J Alzheimers Dis Other Demen; 2017 Mar; 32(2):101-107. PubMed ID: 28191798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease.
    James BD; Bennett DA
    Annu Rev Public Health; 2019 Apr; 40():65-84. PubMed ID: 30642228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease: The next frontier-Special Report 2017.
    Karlawish J; Jack CR; Rocca WA; Snyder HM; Carrillo MC
    Alzheimers Dement; 2017 Apr; 13(4):374-380. PubMed ID: 28314660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harmonized diagnostic criteria for Alzheimer's disease: recommendations.
    Morris JC; Blennow K; Froelich L; Nordberg A; Soininen H; Waldemar G; Wahlund LO; Dubois B
    J Intern Med; 2014 Mar; 275(3):204-13. PubMed ID: 24605805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Cummings J
    Alzheimers Dement; 2019 Jan; 15(1):172-178. PubMed ID: 29936146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].
    Allegri RF; Russo MJ; Kremer J; Taragano FE; Brusco I; Ollari JA; Serrano CM; Sarasola D; Demey I; Arizaga RL; Bagnati P
    Vertex; 2012; 23(101):5-15. PubMed ID: 22880190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do NIA-AA criteria distinguish Alzheimer's disease from frontotemporal dementia?
    Harris JM; Thompson JC; Gall C; Richardson AM; Neary D; du Plessis D; Pal P; Mann DM; Snowden JS; Jones M
    Alzheimers Dement; 2015 Feb; 11(2):207-15. PubMed ID: 25022535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist.
    Budson AE; Solomon PR
    Pract Neurol; 2012 Apr; 12(2):88-96. PubMed ID: 22450454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice.
    Bharadwaj R; Cimino PJ; Flanagan ME; Latimer CS; Gonzalez-Cuyar LF; Juric-Sekhar G; Montine TJ; Marshall DA; Keene CD
    Histopathology; 2018 Feb; 72(3):433-440. PubMed ID: 28815699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.
    Neurobiol Aging; 1997; 18(4 Suppl):S1-2. PubMed ID: 9330978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revision of the criteria for Alzheimer’s disease: A symposium.
    DeKosky ST; Carrillo MC; Phelps C; Knopman D; Petersen RC; Frank R; Schenk D; Masterman D; Siemers ER; Cedarbaum JM; Gold M; Miller DS; Morimoto BH; Khachaturian AS; Mohs RC
    Alzheimers Dement; 2011 Jan; 7(1):e1-12. PubMed ID: 21322828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.
    Reiman EM; McKhann GM; Albert MS; Sperling RA; Petersen RC; Blacker D
    J Clin Psychiatry; 2011 Dec; 72(12):e37. PubMed ID: 22244033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When Does Alzheimer's Disease Really Start? The Role of Biomarkers.
    Lloret A; Esteve D; Lloret MA; Cervera-Ferri A; Lopez B; Nepomuceno M; Monllor P
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.